Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. Fragile X-associated neuropsychiatric disorders (FXAND). Front Psych. 2018;9:564.

Article  Google Scholar 

Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Movement disorders: official journal of the Movement Disorder Society. 2007;22(14):2018–30.

Article  PubMed  Google Scholar 

Hagerman RJ, Hagerman P. Fragile X-associated tremor/ataxia syndrome—features, mechanisms and management. Nat Rev Neurol. 2016;12(7):403–12.

Article  CAS  PubMed  Google Scholar 

Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Human Genetics. 2003;72(4):869–78.

Article  CAS  Google Scholar 

Allen EG, Charen K, Hipp HS, Shubeck L, Amin A, He W, et al. Refining the risk for fragile X–associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size. Genet Med. 2021;23(9):1648–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allen E, Sullivan A, Marcus M, Small C, Dominguez C, Epstein M, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22(8):2142–52.

Article  CAS  PubMed  Google Scholar 

Man L, Lustgarten Guahmich N, Vyas N, Tsai S, Arazi L, Lilienthal D, et al. Ovarian reserve disorders, can we prevent them? A review. Int J Mol Sci. 2022;23(23):15426.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet. 2000;97(3):189–94.

Article  CAS  PubMed  Google Scholar 

Allen EG, Charen K, Hipp HS, Shubeck L, Amin A, He W, et al. Clustering of comorbid conditions among women who carry an FMR1 premutation. Genet Med. 2020;22(4):758–66.

Article  PubMed  PubMed Central  Google Scholar 

Tassone F, Protic D, Allen EG, Archibald AD, Baud A, Brown TW, et al. Insight and recommendations for fragile X-premutation-associated conditions from the fifth international conference on FMR1 premutation. Cells. 2023;12(18):2330.

Article  PubMed  PubMed Central  Google Scholar 

Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, et al. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A. 2012;158(10):2473–81.

Article  CAS  Google Scholar 

Poteet B, Ali N, Bellcross C, Sherman SL, Espinel W, Hipp H, et al. The diagnostic experience of women with fragile X–associated primary ovarian insufficiency (FXPOI). J Assist Reprod Genet. 2023;40(1):179–90.

Article  PubMed  Google Scholar 

Maenner MJ, Baker MW, Broman KW, Tian J, Barnes JK, Atkins A, et al. FMR1 CGG expansions: prevalence and sex ratios. Am J Med Genet B Neuropsychiatr Genet. 2013;162(5):466–73.

Article  CAS  Google Scholar 

Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg J, Mandel D. Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet B Neuropsychiatr Genet. 2012;159(5):589–97.

Article  CAS  PubMed Central  Google Scholar 

Tassone F, Iong KP, Tong T-H, Lo J, Gane LW, Berry-Kravis E, et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2013;4(12):1–13.

Google Scholar 

Hipp HS, Charen KH, Spencer JB, Allen EG, Sherman SL. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). Menopause (New York, NY). 2016;23(9):993.

Article  Google Scholar 

Chen M, Jiang H, Zhang C. Selected genetic factors associated with primary ovarian insufficiency. Int J Mol Sci. 2023;24(5):4423.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodrigues B, Sousa V, Yrigollen CM, Tassone F, Bejarano OV, Allen EG, et al. FMR1 allelic complexity in premutation carriers provides no evidence for a correlation with age at amenorrhea. Reprod Biol Endocrinol. 2024;22:71. https://doi.org/10.1186/s12958-024-01227-5

Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87(3):456–65.

Article  CAS  PubMed  Google Scholar 

Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet. 2006;14(2):253–5.

Article  CAS  PubMed  Google Scholar 

Sullivan A, Marcus M, Epstein M, Allen E, Anido A, Paquin J, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402–12.

Article  CAS  PubMed  Google Scholar 

Tejada M-I, García-Alegría E, Bilbao A, Martínez-Bouzas C, Beristain E, Poch M, et al. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome. Menopause. 2008;15(5):945–9.

Article  PubMed  Google Scholar 

Hoyos LR, Thakur M. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency. J Assist Reprod Genet. 2017;34:315–23.

Article  PubMed  Google Scholar 

Hoffman GE, Le WW, Entezam A, Otsuka N, Tong Z-B, Nelson L, et al. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem. 2012;60(6):439–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve. Obstet Gynecol Surv. 2010;65(8):523–30.

Article  PubMed  Google Scholar 

Rosario R, Stewart HL, Choudhury NR, Michlewski G, Charlet‐Berguerand N, Anderson RA. Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency. FASEB J. 2022;36(11):e22612. https://doi.org/10.1096/fj.202200468RR

Pastore LM, Johnson J. The FMR1 gene, infertility, and reproductive decision-making: a review. Front Genet. 2014;5:97655.

Article  Google Scholar 

Kerr JB, Myers M, Anderson RA. The dynamics of the primordial follicle reserve. Reproduction. 2013;146(6):R205–15.

Article  CAS  PubMed  Google Scholar 

Hung C-C, Lee C-N, Wang Y-C, Chen C-L, Lin T-K, Su Y-N, et al. Fragile X syndrome carrier screening in pregnant women in Chinese Han population. Sci Rep. 2019;9(1):15456.

Article  PubMed  PubMed Central  Google Scholar 

Kim MJ, Kim DJ, Kim SY, Yang JH, Kim MH, Lee SW, et al. Fragile X carrier screening in Korean women of reproductive age. J Med Screen. 2013;20(1):15–20.

Article  PubMed  Google Scholar 

Han S-H, Heo Y-A, Yang Y-H, Kim Y-J, Cho H-I, Lee K-R. Prenatal population screening for fragile X carrier and the prevalence of premutation carriers in. Korea J Genetic Med. 2012;9(2):73–7.

Article  Google Scholar 

Meraj N, Yasin M, Rehman ZU, Tahir H, Jadoon H, Khan N, et al. Fragile X premutation carrier screening in Pakistani preconception women in primary care consultation. BMC Womens Health. 2022;22(1):57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Utine GE, Şimşek-Kiper PÖ, Akgün-Doğan Ö, Ürel-Demir G, Alanay Y, Aktaş D, et al. Fragile X-associated premature ovarian failure in a large Turkish cohort: findings of Hacettepe Fragile X Registry. Eur J Obstetrics & Gynecol Reprod Biol. 2018;221:76–80.

Article  Google Scholar 

Merino S, Ibarluzea N, Maortua H, Prieto B, Rouco I, López-Aríztegui M-A, et al. Associated clinical disorders diagnosed by medical specialists in 188 FMR1 premutation carriers found in the last 25 years in the spanish basque country: a retrospective study. Genes. 2016;7(10):90.

Article  PubMed  PubMed Central